← Leaderboards
Harold R Collard
National Jewish Health
$36,121,069
Attributed
$86,331,061
Total exposure
8
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $13.9M · FY2007–25$20M$15M$10M$5M$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$86,331,061 · 8
By mechanism
UL1$75,855,591 · 1
UM1$5,004,294 · 1
U01$2,048,043 · 1
P01$1,989,428 · 1
K23$756,170 · 1
K24$597,275 · 1
Top collaborators
- Kirsten Bibbins-Domingo6 shared
- Tung T Nguyen4 shared
- Vanessa Jacoby3 shared
- Ganesh Raghu3 shared
- Lindsey Ann Criswell2 shared
- Jose Rodriguez-Santana1 shared
- Max A Seibold1 shared
- Dean Sheppard1 shared
Most similar at National Jewish Health
Same institution · by research overlap
- Ivana V Yang$13,155,768
- Diane Sullivan$3,882,412
- Talmadge E King$1,393,645
- Lisa A Maier$11,952,941
- John Michael Routes$4,411,984
Others in their field
Top investigators on “Clinical Research”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,040,569,537
- Leonard Freedman · Leidos Biomedical Research, Inc.$975,089,882
- Lawrence Corey · Fred Hutchinson Cancer Center$739,766,552
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Jeffrey P Krischer · University Of South Florida$611,867,176
- Barton F Haynes · Duke University$538,862,577
Research focus
Clinical ResearchInnovationInsightClinical DataBaseResourcesResearch PersonnelFutureTranslational ResearchHamman-Rich SyndromeSkillsEnrollmentCollaborationsBlood SpecimenUniversitiesCaliforniaSan FranciscoClinical TrialsBiologicalCohortClinical SciencesTrainingFosteringAcute
Grant awards (31)
Clinical and Translational Science Institute$8,507,126
UL1 · FY2025 · TR
Clinical and Translational Science Institute$8,497,502
UL1 · FY2024 · TR
Clinical and Translational Science Institute$8,476,672
UL1 · FY2023 · TR
Clinical and Translational Science Institute$8,521,506
UL1 · FY2022 · TR · contact PI
Assessing Patient and Community Engagement in Data Governance$137,000
UL1 · FY2022 · TR · contact PI
Clinical and Translational Science Institute$20,131
UL1 · FY2022 · TR · contact PI
Clinical and Translational Science Institute$8,217,430
UL1 · FY2021 · TR · contact PI
Natural History of Viral Induced Airway Dysfunction and Asthma in Minority Children$2,048,043
U01 · FY2021 · HL · contact PI
Clinical and Translational Science Institute$8,561,399
UL1 · FY2020 · TR · contact PI
Clinical and Translational Science Institute$11,194,925
UL1 · FY2019 · TR · contact PI
Patient Oriented Research and Mentoring in Interstitial Lung Disease$119,911
K24 · FY2019 · HL · contact PI
Clinical and Translational Science Institute$13,721,900
UL1 · FY2018 · TR · contact PI
Patient Oriented Research and Mentoring in Interstitial Lung Disease$119,911
K24 · FY2018 · HL · contact PI
20th Biennial International Conference on Lung and Airway Fibrosis (ICLAF)$30,000
R13 · FY2018 · HL · contact PI
Patient Oriented Research and Mentoring in Interstitial Lung Disease$119,911
K24 · FY2017 · HL · contact PI
Longitudinal Cohort/Sheppard$493,142
P01 · FY2016 · HL · contact PI
Patient Oriented Research and Mentoring in Interstitial Lung Disease$118,771
K24 · FY2016 · HL · contact PI
Treatment of IPF with Laparoscopic Anti-reflux Surgery$1,986,142
UM1 · FY2015 · HL · contact PI
Longitudinal Cohort/Sheppard$348,306
P01 · FY2015 · HL · contact PI
Patient Oriented Research and Mentoring in Interstitial Lung Disease$118,771
K24 · FY2015 · HL · contact PI
Treatment of IPF with Laparoscopic Anti-reflux Surgery$1,942,327
UM1 · FY2014 · HL · contact PI
Longitudinal Cohort/Sheppard$379,265
P01 · FY2014 · HL · contact PI
Treatment of IPF with Laparoscopic Anti-reflux Surgery$1,075,825
UM1 · FY2013 · HL · contact PI
Longitudinal Cohort/Sheppard$368,702
P01 · FY2013 · HL · contact PI
Longitudinal Cohort/Sheppard$400,013
P01 · FY2012 · HL · contact PI
Defining Acute Exacerbations of Idiopathic Pulmonary Fibrosis$152,692
K23 · FY2011 · HL · contact PI
Defining Acute Exacerbations of Idiopathic Pulmonary Fibrosis$152,692
K23 · FY2010 · HL · contact PI
Defining Acute Exacerbations of Idiopathic Pulmonary Fibrosis$151,072
K23 · FY2009 · HL · contact PI
Defining Acute Exacerbations of Idiopathic Pulmonary Fibrosis$151,072
K23 · FY2008 · HL · contact PI
Defining Acute Exacerbations of Idiopathic Pulmonary Fibrosis$148,642
K23 · FY2007 · HL · contact PI
Apoptotic Cell Removal in Idiopathic Pulmonary Fibrosis$50,260
F32 · FY2004 · HL